Antibody Production Market - Forecast(2024 - 2030)
Overview
Antibody Production Market
is projected to reach revenue of $22.5 billion by 2025, and is estimated to
grow at a CAGR of 12.8% during the forecast period 2019-2025. The Antibody
Production market size, in 2018, is $9.7 billion. Antibody production by various
biotechnology companies is to make medicines or diagnostic tests. The
antibodies are mainly used to develop treatments for cancer and diseases such
as arthritis, sclerosis, and others.
Key Takeaways
The market is estimated to grow at a CAGR of 12.8% owing to the rising rate of infectious diseases and increasing investments by biotechnology companies to develop treatment for various chronic diseases.
Companies are adopting various strategic alliances to expand in various regions. Investments in antibody production and research have increased in order to develop treatment for deadly diseases such as cancer.
Cancer treatment is observed to be more effective when multiple methods are used. Treatment methods such as stem cell transplantation along with antibody treatment has improved the survival rate of patients. Advances in biotechnology and antibody production have led to the development of various therapies for common diseases.
Process - Segment Analysis
Downstream processing is
having major share by revenue in the owing to the large use of chromatography
systems and resins for antibody production.
This process is highly accurate, sensitive and effective, making its use
popular for the production of antibodies.
Type - Segment Analysis
Main types of antibodies
produced are monoclonal and polyclonal antibodies. Monoclonal antibodies are
clones of the parent cell and Polyclonal antibodies are made from different
cells. Monoclonal antibodies are dominant segment compared to polyclonal
antibodies and have a CAGR of 11.2%. They are having more demand for treatment
of infections, cancer, and other chronic diseases. A common method of
preparation of monoclonal antibodies is using ion exchange chromatography. This
is because with this method, the process can be controlled easily and has high
capacity or purification capability. Ammonium sulfate precipitation is used for
monoclonal and polyclonal isolation.
End-User - Segment Analysis
Pharmaceutical and
biotechnological companies are having larger share by end-user segment. This is
because of the production of antibodies especially for these companies and due
to the high investment for research and development by such companies.
Geography - Segment Analysis
North America accounts for
largest Antibody Production market share with 32.3% in 2018. This is owing to
the presence of various biotechnology companies present here. Also, the
government expenditure for healthcare sector in North America is high. These
factors contribute to the growth of the market in this region. However, Asia
Pacific will have higher growth rate in the coming years due to supportive
regulations and increasing innovations by the companies here.
Drivers – Antibody Production Market
· Rising rate of chronic diseasesAntibodies protect body by strengthening the immune system. They are used to prevent virus or bacteria related diseases. Antibodies are produced for various infections and are given to people as immunizations. They are also being developed for treatment of cancer and arthritis. Gastric cancer is said to be the second leading cause of global cancer-related deaths. Thus the antibody production will contribute to gastroenterology. The major gastric cancer treatment antibodies include Ramucirumab and Trastuzumab.
· Increase in expenditure by biotechnology companies
Biosimilars are gaining popularity as they serve the same purpose as the biologic and are also less expensive. With many patent expirations in the coming years, the biotechnology companies are investing in development of biosimilars. They are also increasing expenditure for research and developments for antibody production processes.
Challenges – Antibody Production Market
·
High cost of production
Antibody production
requires heavy expense by the companies. Their expenditure and investments for
antibody production will be high. The high cost for antibody production will challenge
the market.
Antibody Production Industry Outlook
Research & development along
with strategic alliances are some of the key strategies adopted by players in
the Antibody Production market. Antibody Production Market top 10 companies are
Cellab Gmbh, Eppendorf Ag, Integra Bioscience Ag, Merck Kgaa, Pall Corp,
Sartorius Ag, Thermo Fisher Scientific, Inc, ProteoGenix, Genentech, Inc. and BIOTEM.
Antibody Production Market Research Scope:
The base year of the study
is 2018, with forecast done up to 2025. The study presents a thorough analysis
of the competitive landscape, taking into account the market shares of the
leading companies. These provide the key market participants with the necessary
business intelligence and help them understand the future of the Antibody
Production Market. The assessment includes the forecast, an overview of the
competitive structure, the market shares of the competitors, as well as the
market trends, market demands, market drivers, market challenges, and product
analysis. The market drivers and restraints have been assessed to fathom their
impact over the forecast period. This report further identifies the key
opportunities for growth while also detailing the key challenges and possible
threats.
1.1 Definitions and Scope
2. Antibody Production Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Antibody Production Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Antibody Production Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Antibody Production Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Antibody Production Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Antibody Production Market - Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Antibody Production Market - By Process (Market Size -$Million / $Billion)
8.1 Upstream processing
8.1.1 Bioreactors
8.1.1.1 Large-scale bioreactors
8.1.1.2 Single-use bioreactors
8.1.2 Consumables
8.1.2.1 Media
8.1.2.2 Buffers and reagents
8.2 Downstream processing
8.2.1 Chromatography systems
8.2.2 Chromatography resins
8.3 Filtration
8.3.1 Filtration systems
8.3.2 Filtration consumables and accessories
9. Antibody Production Market - By Type (Market Size -$Million / $Billion)
9.1 Polyclonal antibody
9.2 Monoclonal antibody
9.2.1 Murine monoclonal antibody
9.2.2 Chimeric monoclonal antibody
9.2.3 Humanized monoclonal antibody
10. Antibody Production - By End User (Market Size -$Million / $Billion)
10.1 Pharmaceutical and biotechnology companies
10.2 Research laboratories
10.3 Others
11. Antibody Production - By Geography (Market Size -$Million / $Billion)
11.1 Antibody Production Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Antibody Production- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Antibody Production- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Antibody Production - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Antibody Production - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Antibody Production Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Antibody Production Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Antibody Production Market - Key Company List by Country Premium
15. Antibody Production Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Cellab Gmbh
15.3 Eppendorf Ag
15.4 Integra Bioscience Ag
15.5 Merck Kgaa
15.6 Pall Corp
15.7 Sartorius Ag
15.8 Thermo Fisher Scientific, Inc
15.9 Company 8
15.10 Company 9 & More
16.1 Abbreviations
16.2 Sources
17. Antibody Production Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends